A study of electromyographic findings in patients with progressive muscular dystrophy during remetabolizing therapy.
D000227:Adenine Nucleotides / Q000627:therapeutic use; D045930:Anabolic Agents / Q000627:therapeutic use; D001223:Aspartate-Semialdehyde Dehydrogenase; D001224:Aspartic Acid / Q000627:therapeutic use; D004576:Electromyography; D006801:Humans; D007294:Inositol / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D008715:Methionine / Q000627:therapeutic use; D009136:Muscular Dystrophies / Q000188:drug therapy*; D011188:Potassium / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D000227:Adenine Nucleotides; D045930:Anabolic Agents; D014810:Vitamin E; D001224:Aspartic Acid; D007294:Inositol; D008715:Methionine; D001223:Aspartate-Semialdehyde Dehydrogenase; D008274:Magnesium; D011188:Potassium